MedTrace Logo

Hemodynamic Assessment in Acute Decompensated Heart Failure

NCT03535909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2019-03-26

No results posted yet for this study

Summary

This study will assess the ability of a novel optical measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure. Patients will be measured with both the novel measurement system and reference devices that are FDA-cleared for hemodynamic measurements. The measurements from the novel system will be compared to reference variables describing hemodynamic and congestive status, including stroke volume, central venous pressure, and serum levels of NT-proBNP.

Conditions

  • Congestive Heart Failure

Interventions

DIAGNOSTIC_TEST

Noninvasive Hemodynamic Measurement System

Ability of the noninvasive hemodynamic measurement system to determine changes in the hemodynamic status of heart failure patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure.

Sponsors & Collaborators

  • University of Split, School of Medicine

    collaborator OTHER

  • Rodin Scientific LLC

    lead INDUSTRY

Principal Investigators

  • Elena Allen, PhD · Rodin Scientific

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-09
Primary Completion
2018-06-24
Completion
2018-07-31
FDA Device
Yes

Countries

  • United States
  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535909 on ClinicalTrials.gov